Neuphoria FY26 loss widens to $13.59 million; revenue drops 92.5% to $1.17 million
Bitget2026/09/18 20:11- Neuphoria posted a pre-tax loss of USD 13.59 million, widening from USD 0.84 million a year earlier.
- Revenue fell 92.5% to USD 1.17 million, versus a year-ago period that included a USD 15 million Merck milestone.
- Research and development expense dropped 60.6% to USD 3.55 million, while general and administrative costs edged down 4.3% to USD 7.44 million.
- Results included USD 1.28 million of restructuring costs after an October 2025 plan to pause BNC210 work and cut headcount.
- Other income climbed to USD 2.86 million, and the company recorded a USD 5.36 million goodwill impairment tied to Merck’s MK-1167 trial cancellation.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Meta (META.US) data center's first high-yield bond is oversubscribed more than four times, strong demand drives premium issuance
The first junk bond issuance by the data center division of Meta Platforms attracted demand over four times the transaction size, with its enticing yields drawing in investors.
US stock index adjustments to take effect next Monday: Bloom Energy (BE.US) and Everpure (P.US) to be included in S&P 500, changes also for mid- and small-cap stocks
Bloom Energy, Illumina, and Everpure will be included in the S&P 500 index, while several other companies will be added to the S&P 100, S&P MidCap 400, and S&P SmallCap 600 indices.
Is the Federal Reserve repeating the 2022-style rate hikes? Bank of America warns: Rates may return above 5%, suggests shorting two-year U.S. Treasuries.
Bank of America warns: With Waller at the helm, the Federal Reserve may raise interest rates above 5%, potentially repeating the events of 2022.
Crypto prices
More
